Breakfast with the Market — October 24, 2026

Good morning, everyone. Today's menu is packed: Middle East geopolitics, a billion-dollar merger coming out of the oven, AI invading medicine, and another regulatory arm-wrestling match in Washington. Let's get straight to it, because the market won't wait for anyone to finish their coffee.

Oil on Fire in the Strait of Hormuz

The fact: Iran stated that seven oil tankers were attacked in the Strait of Hormuz, reigniting fears of a return to open conflict and driving up the oil risk premium.

I'd Buy — I'm buying protection (options and physical oil via ETFs like USO), because any partial closure of the strait cuts roughly 20% of global crude flow.

Affected assets/sectors:

• XOM and CVX — majors benefit from pricier barrels.
• USO (oil ETF) — direct hedge against escalation.
• Air transport sector (JETS) — expensive fuel squeezes margins.
• Goldman Sachs (GS) — trading volatility boosts commodities results.

Musk Merges Tesla and SpaceX: A $3.5 Trillion Merger?

The fact: Musk signaled that a merger between Tesla and SpaceX, valued together at over $3.5 trillion, is "a good idea" and became the market's talking point.

I'd Reduce — I love the storytelling, but merging with SpaceX puts a private, illiquid valuation inside TSLA's balance sheet. For those positioned, I'd trim partially and take profits.

Affected assets/sectors:

• TSLA — risk of dilution and corporate complexity.
• BTC — the eventual corporate giant would hold a billion-dollar Bitcoin treasury, creating a new institutional "proxy."
• ARKK — Cathie Wood's fund becomes even more concentrated on the Musk theme.
• Satellite suppliers — possible consolidation wave in the aerospace sector.

Microsoft's AI Schools Doctors — and the Healthcare Market Shakes

The fact: Mustafa Suleyman of Microsoft stated that the company's AI outperforms doctors in diagnosing difficult cases, targeting "medical superintelligence."

I'd Buy — MSFT is turning Azure + AI into a high-margin recurring revenue funnel, and healthcare is the biggest untouched pie.

Affected assets/sectors:

• MSFT — owns the technology, the main winner.
• NVDA — training infrastructure, direct beneficiary.
• TDOC (telemedicine) — price pressure if AI reduces diagnostic costs.
• Health-tech sector — reassessment of business models.

Melanoma Vaccine Cuts Recurrence by 42%

The fact: Moderna and Merck presented results from an advanced-stage trial showing that the personalized mRNA vaccine reduces melanoma recurrence risk by 42%.

I'd Buy — it's the proof of concept the market was waiting for to take mRNA beyond covid. I'm buying MRNA with conviction and see relevant upside in the pipeline.

Affected assets/sectors:

• MRNA — owns the platform, biggest beneficiary.
• MRK — partner in the study, gains oncology optionality.
• Traditional oncology — competing therapies may lose ground.
• Biotech sector — renewed sentiment for mRNA.

Washington Turns Off the Tap for AI and Semiconductors Abroad

The fact: The US Treasury proposed rules to block American investments in AI and semiconductors abroad, with a focus on China and strategic adversaries.

I'd Hold — it's short-term noise that reinforces the moat of domestic champions. I'm holding NVDA and AMD, but with a lean position and tight stop, because the execution of these rules could become a headache.

Affected assets/sectors:

• NVDA and AMD — regulatory protection against Chinese competition.
• SMH (semiconductor ETF) — short-term volatility.
• ASML — China exposure is the biggest source of risk.
• TSM — the most sensitive link in the chain.

Emerging Markets Return to Center Stage

The fact: Economist Iyabo Masha told investors that emerging markets are central to global growth and need long-term capital to gain productivity.

I'd Buy — with the dollar on hold and US rates falling, emerging markets become attractive. I'm buying EEM and keeping a close eye on Brazil via EWZ.

Affected assets/sectors:

• EEM (emerging markets ETF) — broad diversification.
• EWZ (Brazil ETF) — beneficiary of foreign flows.
• Commodities — exporting emerging markets gain from demand.
• Investment banks — recovery in issuance across the bloc.

Coral Reefs: The Tragedy the Market Still Ignores

The fact: A study classified